If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
I think this statement is incorrect & should read 33.44% in public hands,the rest is held by institutions. In the terms of AIM Rules published 13 May 2014 and insofar as it is aware 33.44% of the Company's AIM securities were not in public hands.
Major Shareholders (as at 1 August 2014) Shareholders holding more than 3% of the share capital (voting rights) of TyraTech, Inc. are: American Vanguard Corp 24.09% Legal & General 11.93% Sustainable Asset Management 6.62% Alan Reade (Non-Executive Chairman) 4.98% Close Asset Management 4.17% Henderson Global Investors 3.74% Shares Not in Public Hands (as at 3 March 2014) In the terms of AIM Rules published 13 May 2014 and insofar as it is aware 33.44% of the Company's AIM securities were not in public hands. Director Holdings (as at 1 August 2014) Each director's holdings of the share capital (voting rights) of TyraTech, Inc. are: Alan Reade 4.98% Barry Riley 1.25% Bruno Jactel 0.79% James Hills 0.47%
Unlike other products that only kill the head-lice,this does both in one go. http://www.wral.com/triangle-company-develops-new-treatment-for-lice/13611309/
There products go on sale next month in the UK. Might take a few months before we are updated on sales. This board sure is quiet,im talking among myself on the other board. We are number 3 out of 15 products only after 3 months sales. Lets see where we stand at the end of the year,i have no doubt we will take number 1 spot.
This is only after 3 months. “The performance in Walmart has been very good, and we're also very please with our supply chain: supplying 4,200 stores is always a challenge but we have seen 99.68 per cent in on time-right place deliveries and we're very pleased with that,” says Reade. “They have also started to increase their stocking rate. Walmart carries very lean stock, it's how they do business, and we are now number three in the category out of the 12-15 products in that category so we're very pleased with that.”
This is a company growing in scale and confidence, buoyed by its initial success in the US, where it sells its Vamousse range both online and in stores through the retail behemoth Walmart. Reade says the appetite for the product has been “excellent”.
“The performance in Walmart has been very good, and we're also very please with our supply chain: supplying 4,200 stores is always a challenge but we have seen 99.68 per cent in on time-right place deliveries and we're very pleased with that,” says Reade. “They have also started to increase their stocking rate. Walmart carries very lean stock, it's how they do business, and we are now number three in the category out of the 12-15 products in that category so we're very pleased with that.”
Will take time for people to notice this company. Once there sales increase & people start talking about there products this will really take of. No doubt you are ware of the advantage of there products,there 100% safe. No other product on the market can make this claim. I will also be holding onto these share,not many companies with this so much potential.
Yes i know these can not be put into a crest account,but they can be put into a nominee account. After one year they can be converted to the other shares. If TYRU are higher on conversion then you will gain the difference for free.
There products will be for sale in the UK next month. There is a huge demand for there products which are not only %100 safe,they are just affective as the competition & in most cases more affective. Check out the reviews on Amazon & they are talking about our products on mums-net. The launch of the Vamousse product range in the UK is a further significant strategic step in the commercialisation of our strong intellectual property. To have obtained listings and partner relationships with both Boots and Superdrug further validates the potential of the Vamousse range of products. The oversubscribed placing, which was supported both by existing and new shareholders, will provide the working capital for a successful launch in the UK. The Board believes that this could be the first step of a broader European expansion for Vamousse and other TyraTech products in the future."
***********/archives/tip-tv-finance-show-21-07-2014/ Fast-forward the video to 12.23. 10 new products will be launched next month. %30 of children will get head-lice,they will also sell a preventative shampoo. The director believe his company is worth allot more on one product alone,they have 10 new product coming to the market next month & he believe they have a gloabal potnetial. Alan Reade - Chairman TyraTech - Discussion on TyraTech - Tyra Tech Inc. (TYRA), Tyra Tech Inc. (TYR.L). - See more at: ***********/archives/tip-tv-finance-show-21-07-2014/#sthash.6tarA6qw.wBNcoQmg.dpuf
hxxp://www.***********/archives/tip-tv-finance-show-21-07-2014/ Fast-forward the video to 12.23. 10 new products will be launched next month. %30 of children will get head-lice,they will also sell a preventative shampoo. The director believe his company is worth allot more on one product alone,they have 10 new product coming to the market next month & he believe they have a gloabal potnetial. Alan Reade - Chairman TyraTech - Discussion on TyraTech - Tyra Tech Inc. (TYRA), Tyra Tech Inc. (TYR.L). - See more at: hxxp://www.***********/archives/tip-tv-finance-show-21-07-2014/#sthash.6tarA6qw.wBNcoQmg.dpuf
There is no doubt both share will follow each other. One will lang behind the other,if both where to increase %1000,then that would be huge gains for all those involved. However if someone where to buy in here & this one where to lag by %20,then on conversion you would not have a extra not %20 on your initial investment but a extra %200.
You could go & visit walmart & check out how well there products are selling. Ask a assistant to recommend a product & see which one they pick. For over 50 years the only alternative was a chemical based product,as you say they are hazardous. We now have product which is %100 safe. The competitive advantage of having a product that is 100% safe is obvious. They have another product which i believe will be even bigger,one for treating flees in animals. I know someone who breads dogs & they are very interested in there product.
You might have to fill in this form if you want to buy this share,can print it out & hand it into your broker. https://help.stockbrokers.barclays.co.uk/help/portfolio/W8_BEN
MARKET REPORT: Head lice treatment hits right spot for Tyratech as shares rise following product launch in Superdrug and Boots Read more: http://www.thisismoney.co.uk/money/markets/article-2694998/MARKET-REPORT-Head-lice-allow-Tyratech-ahead-UK.html#ixzz385zcCIIn Follow us: @MailOnline on Twitter | DailyMail on Facebook http://www.thisismoney.co.uk/money/markets/article-2694998/MARKET-REPORT-Head-lice-allow-Tyratech-ahead-UK.html